Literature DB >> 2820384

Ontogenetic changes in adenylate cyclase, cyclic AMP phosphodiesterase and calmodulin in chick ventricular myocardium.

P M Epstein, D M Andrenyak, C J Smith, A J Pappano.   

Abstract

The activities of cyclic AMP phosphodiesterase (3',5'-cyclic nucleotide 5'-nucleotidohydrolase, EC 3.1.4.17) and adenylate cyclase [ATP pyrophosphate-lyase (cyclizing), EC 4.6.1.1] and calmodulin content during development of chick ventricular myocardium were determined. The specific activity of cyclic AMP phosphodiesterase was relatively low in early embryos, increased during embryogenesis by about 4-fold to reach highest values just before hatching, and then decreased by approx. 30% within 1 week after hatching. In contrast, adenylate cyclase did not change during embryonic development, but increased by approx. 50% within 1 week after hatching. Calmodulin content remained constant at 9 micrograms/g wet wt. during embryonic development and decreased to 6 micrograms/g wet wt. by 1 week after hatching. DEAE-Sephacel chromatography of chick ventricular supernatant revealed a single major form of cyclic nucleotide phosphodiesterase activity in early embryonic (9-day E) and hatched (6-day H) chicks. This enzyme form was eluted at approx. 0.27 M-sodium acetate, hydrolysed both cyclic AMP and cyclic GMP, and was sensitive to stimulation by Ca2+-calmodulin, with an apparent Km for calmodulin of approx. 1 nM. In contrast, ventricular supernatant from late-embryonic (18-day E) chicks contained two forms of phosphodiesterase separable on DEAE-Sephacel: the same form as that seen at other ages, plus a cyclic AMP-specific form which was eluted at approx. 0.65 M-sodium acetate and was insensitive to stimulation by Ca2+-calmodulin. The ontogenetic changes in cyclic AMP phosphodiesterase activity in chick ventricular myocardium are consistent with reported ontogenetic changes in the steady-state contents of cyclic AMP in this tissue and suggest that this enzyme may be responsible for the changes that occur in this nucleotide during development of chick myocardium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820384      PMCID: PMC1147886          DOI: 10.1042/bj2430525

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  High cyclic AMP levels in young chick embryonic hearts.

Authors:  M J McLean; R A Lapsley; K Shigenobu; F Murad; N Sperelakis
Journal:  Dev Biol       Date:  1975-01       Impact factor: 3.582

2.  Regulation of cyclic nucleotide phosphodiesterase.

Authors:  M M Appleman; W L Terasaki
Journal:  Adv Cyclic Nucleotide Res       Date:  1975

3.  Calcium ions regulate cyclic AMP and beating in cultured heart cells.

Authors:  I Harary; J F Renaud; E Sato; G A Wallace
Journal:  Nature       Date:  1976-05-06       Impact factor: 49.962

4.  Catalytic and regulatory properties of two forms of bovine heart cyclic nucleotide phosphodiesterase.

Authors:  C Ho; T S Teo; R Desai; J H Wang
Journal:  Biochim Biophys Acta       Date:  1976-04-08

5.  Reciprocal changes in Ca2+/protein activator-dependent and-independent cyclic AMP phosphodiesterase during the development of chick embryos.

Authors:  Y Tanigawa; M Shimoyama; J Tai; K Fujii; I Ueda
Journal:  Biochem Biophys Res Commun       Date:  1976-11-08       Impact factor: 3.575

6.  Frequency dependence of cyclic AMP in mammalian myocardium.

Authors:  M Endoh; O E Brodde; D Reinhardt; H J Schümann
Journal:  Nature       Date:  1976-06-24       Impact factor: 49.962

7.  Cyclic 3',5'-nucleotide phosphodiesterase. Distribution and developmental changes of the enzyme and its protein activator in mammalian tissues and cells.

Authors:  J A Smoake; S Y Song; W Y Cheung
Journal:  Biochim Biophys Acta       Date:  1974-04-25

8.  The role of potassium and calcium ions in the effect of epinephrine on cardiac cyclic adenosine 3',5'-monophosphate, phosphorylase kinase, and phosphorylase.

Authors:  D H Namm; S E Mayer; M Maltbie
Journal:  Mol Pharmacol       Date:  1968-09       Impact factor: 4.436

9.  Muscarinic antagonism of the effects of phosphodiesterase inhibitor (methylisobutylxanthine) in embryonic chick ventricle.

Authors:  R L Biegon; P M Epstein; A J Pappano
Journal:  J Pharmacol Exp Ther       Date:  1980-11       Impact factor: 4.030

10.  The role of cyclic adenosine 3', 5'-monophosphate and calcium in the regulation of contractility and glycogen phosphorylase activity in guinea pig papillary muscle.

Authors:  J G Dobson; J Ross; S E Mayer
Journal:  Circ Res       Date:  1976-09       Impact factor: 17.367

View more
  2 in total

1.  Identification and characterization of a Ca2+-calmodulin-sensitive cyclic nucleotide phosphodiesterase in a human lymphoblastoid cell line.

Authors:  P M Epstein; S Moraski; R Hachisu
Journal:  Biochem J       Date:  1987-04-15       Impact factor: 3.857

Review 2.  Phosphodiesterase inhibition in heart failure.

Authors:  Matthew Movsesian; Josef Stehlik; Fabrice Vandeput; Michael R Bristow
Journal:  Heart Fail Rev       Date:  2008-12-19       Impact factor: 4.214

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.